Vaccines Administered Orally Market

1 Study Coverage
    1.1 Vaccines Administered Orally Product Introduction
    1.2 Market by Type
        1.2.1 Global Vaccines Administered Orally Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Human
        1.2.3 Animal
    1.3 Market by Application
        1.3.1 Global Vaccines Administered Orally Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Public
        1.3.3 Private
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Vaccines Administered Orally Sales Estimates and Forecasts 2017-2028
    2.2 Global Vaccines Administered Orally Revenue Estimates and Forecasts 2017-2028
    2.3 Global Vaccines Administered Orally Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Vaccines Administered Orally Sales by Region
        2.4.1 Global Vaccines Administered Orally Sales by Region (2017-2022)
        2.4.2 Global Sales Vaccines Administered Orally by Region (2023-2028)
    2.5 Global Vaccines Administered Orally Revenue by Region
        2.5.1 Global Vaccines Administered Orally Revenue by Region (2017-2022)
        2.5.2 Global Vaccines Administered Orally Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Vaccines Administered Orally Sales by Manufacturers
        3.1.1 Global Top Vaccines Administered Orally Manufacturers by Sales (2017-2022)
        3.1.2 Global Vaccines Administered Orally Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines Administered Orally in 2021
    3.2 Global Vaccines Administered Orally Revenue by Manufacturers
        3.2.1 Global Vaccines Administered Orally Revenue by Manufacturers (2017-2022)
        3.2.2 Global Vaccines Administered Orally Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Vaccines Administered Orally Revenue in 2021
    3.3 Global Vaccines Administered Orally Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Vaccines Administered Orally Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Vaccines Administered Orally Sales by Type
        4.1.1 Global Vaccines Administered Orally Historical Sales by Type (2017-2022)
        4.1.2 Global Vaccines Administered Orally Forecasted Sales by Type (2023-2028)
        4.1.3 Global Vaccines Administered Orally Sales Market Share by Type (2017-2028)
    4.2 Global Vaccines Administered Orally Revenue by Type
        4.2.1 Global Vaccines Administered Orally Historical Revenue by Type (2017-2022)
        4.2.2 Global Vaccines Administered Orally Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
    4.3 Global Vaccines Administered Orally Price by Type
        4.3.1 Global Vaccines Administered Orally Price by Type (2017-2022)
        4.3.2 Global Vaccines Administered Orally Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Vaccines Administered Orally Sales by Application
        5.1.1 Global Vaccines Administered Orally Historical Sales by Application (2017-2022)
        5.1.2 Global Vaccines Administered Orally Forecasted Sales by Application (2023-2028)
        5.1.3 Global Vaccines Administered Orally Sales Market Share by Application (2017-2028)
    5.2 Global Vaccines Administered Orally Revenue by Application
        5.2.1 Global Vaccines Administered Orally Historical Revenue by Application (2017-2022)
        5.2.2 Global Vaccines Administered Orally Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
    5.3 Global Vaccines Administered Orally Price by Application
        5.3.1 Global Vaccines Administered Orally Price by Application (2017-2022)
        5.3.2 Global Vaccines Administered Orally Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Vaccines Administered Orally Market Size by Type
        6.1.1 North America Vaccines Administered Orally Sales by Type (2017-2028)
        6.1.2 North America Vaccines Administered Orally Revenue by Type (2017-2028)
    6.2 North America Vaccines Administered Orally Market Size by Application
        6.2.1 North America Vaccines Administered Orally Sales by Application (2017-2028)
        6.2.2 North America Vaccines Administered Orally Revenue by Application (2017-2028)
    6.3 North America Vaccines Administered Orally Market Size by Country
        6.3.1 North America Vaccines Administered Orally Sales by Country (2017-2028)
        6.3.2 North America Vaccines Administered Orally Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Vaccines Administered Orally Market Size by Type
        7.1.1 Europe Vaccines Administered Orally Sales by Type (2017-2028)
        7.1.2 Europe Vaccines Administered Orally Revenue by Type (2017-2028)
    7.2 Europe Vaccines Administered Orally Market Size by Application
        7.2.1 Europe Vaccines Administered Orally Sales by Application (2017-2028)
        7.2.2 Europe Vaccines Administered Orally Revenue by Application (2017-2028)
    7.3 Europe Vaccines Administered Orally Market Size by Country
        7.3.1 Europe Vaccines Administered Orally Sales by Country (2017-2028)
        7.3.2 Europe Vaccines Administered Orally Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Vaccines Administered Orally Market Size by Type
        8.1.1 Asia Pacific Vaccines Administered Orally Sales by Type (2017-2028)
        8.1.2 Asia Pacific Vaccines Administered Orally Revenue by Type (2017-2028)
    8.2 Asia Pacific Vaccines Administered Orally Market Size by Application
        8.2.1 Asia Pacific Vaccines Administered Orally Sales by Application (2017-2028)
        8.2.2 Asia Pacific Vaccines Administered Orally Revenue by Application (2017-2028)
    8.3 Asia Pacific Vaccines Administered Orally Market Size by Region
        8.3.1 Asia Pacific Vaccines Administered Orally Sales by Region (2017-2028)
        8.3.2 Asia Pacific Vaccines Administered Orally Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Vaccines Administered Orally Market Size by Type
        9.1.1 Latin America Vaccines Administered Orally Sales by Type (2017-2028)
        9.1.2 Latin America Vaccines Administered Orally Revenue by Type (2017-2028)
    9.2 Latin America Vaccines Administered Orally Market Size by Application
        9.2.1 Latin America Vaccines Administered Orally Sales by Application (2017-2028)
        9.2.2 Latin America Vaccines Administered Orally Revenue by Application (2017-2028)
    9.3 Latin America Vaccines Administered Orally Market Size by Country
        9.3.1 Latin America Vaccines Administered Orally Sales by Country (2017-2028)
        9.3.2 Latin America Vaccines Administered Orally Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Vaccines Administered Orally Market Size by Type
        10.1.1 Middle East and Africa Vaccines Administered Orally Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Vaccines Administered Orally Revenue by Type (2017-2028)
    10.2 Middle East and Africa Vaccines Administered Orally Market Size by Application
        10.2.1 Middle East and Africa Vaccines Administered Orally Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Vaccines Administered Orally Revenue by Application (2017-2028)
    10.3 Middle East and Africa Vaccines Administered Orally Market Size by Country
        10.3.1 Middle East and Africa Vaccines Administered Orally Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Vaccines Administered Orally Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck
        11.1.1 Merck Corporation Information
        11.1.2 Merck Overview
        11.1.3 Merck Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Corporation Information
        11.3.2 Sanofi Overview
        11.3.3 Sanofi Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Recent Developments
    11.4 Lanzhou Institute
        11.4.1 Lanzhou Institute Corporation Information
        11.4.2 Lanzhou Institute Overview
        11.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Lanzhou Institute Recent Developments
    11.5 Serum Institute
        11.5.1 Serum Institute Corporation Information
        11.5.2 Serum Institute Overview
        11.5.3 Serum Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Serum Institute Recent Developments
    11.6 Valneva
        11.6.1 Valneva Corporation Information
        11.6.2 Valneva Overview
        11.6.3 Valneva Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Valneva Recent Developments
    11.7 Shanghai United Cell
        11.7.1 Shanghai United Cell Corporation Information
        11.7.2 Shanghai United Cell Overview
        11.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Shanghai United Cell Recent Developments
    11.8 Bibcol
        11.8.1 Bibcol Corporation Information
        11.8.2 Bibcol Overview
        11.8.3 Bibcol Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bibcol Recent Developments
    11.9 PaxVax
        11.9.1 PaxVax Corporation Information
        11.9.2 PaxVax Overview
        11.9.3 PaxVax Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 PaxVax Recent Developments
    11.10 Vabiotech
        11.10.1 Vabiotech Corporation Information
        11.10.2 Vabiotech Overview
        11.10.3 Vabiotech Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Vabiotech Recent Developments
    11.11 Tiantan Biological
        11.11.1 Tiantan Biological Corporation Information
        11.11.2 Tiantan Biological Overview
        11.11.3 Tiantan Biological Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Tiantan Biological Recent Developments
    11.12 EuBiologics
        11.12.1 EuBiologics Corporation Information
        11.12.2 EuBiologics Overview
        11.12.3 EuBiologics Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 EuBiologics Recent Developments
    11.13 Panacea Biotec Ltd
        11.13.1 Panacea Biotec Ltd Corporation Information
        11.13.2 Panacea Biotec Ltd Overview
        11.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Panacea Biotec Ltd Recent Developments
    11.14 Bio-Med
        11.14.1 Bio-Med Corporation Information
        11.14.2 Bio-Med Overview
        11.14.3 Bio-Med Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Bio-Med Recent Developments
    11.15 Halfkin Bio-Pharmaceuticals
        11.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
        11.15.2 Halfkin Bio-Pharmaceuticals Overview
        11.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Vaccines Administered Orally Industry Chain Analysis
    12.2 Vaccines Administered Orally Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Vaccines Administered Orally Production Mode & Process
    12.4 Vaccines Administered Orally Sales and Marketing
        12.4.1 Vaccines Administered Orally Sales Channels
        12.4.2 Vaccines Administered Orally Distributors
    12.5 Vaccines Administered Orally Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Vaccines Administered Orally Industry Trends
    13.2 Vaccines Administered Orally Market Drivers
    13.3 Vaccines Administered Orally Market Challenges
    13.4 Vaccines Administered Orally Market Restraints
14 Key Findings in The Global Vaccines Administered Orally Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Vaccines Administered Orally Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Human
    Table 3. Major Manufacturers of Animal
    Table 4. Global Vaccines Administered Orally Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Vaccines Administered Orally Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
    Table 7. Global Vaccines Administered Orally Sales Market Share by Region (2017-2022)
    Table 8. Global Vaccines Administered Orally Sales by Region (2023-2028) & (K Units)
    Table 9. Global Vaccines Administered Orally Sales Market Share by Region (2023-2028)
    Table 10. Global Vaccines Administered Orally Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
    Table 12. Global Vaccines Administered Orally Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Vaccines Administered Orally Revenue Market Share by Region (2023-2028)
    Table 14. Global Vaccines Administered Orally Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Vaccines Administered Orally Sales Share by Manufacturers (2017-2022)
    Table 16. Global Vaccines Administered Orally Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Vaccines Administered Orally Revenue Share by Manufacturers (2017-2022)
    Table 18. Vaccines Administered Orally Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Vaccines Administered Orally Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Vaccines Administered Orally by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines Administered Orally as of 2021)
    Table 21. Vaccines Administered Orally Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Vaccines Administered Orally Product Offered
    Table 23. Date of Manufacturers Enter into Vaccines Administered Orally Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 26. Global Vaccines Administered Orally Sales by Type (2023-2028) & (K Units)
    Table 27. Global Vaccines Administered Orally Sales Share by Type (2017-2022)
    Table 28. Global Vaccines Administered Orally Sales Share by Type (2023-2028)
    Table 29. Global Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Vaccines Administered Orally Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Vaccines Administered Orally Revenue Share by Type (2017-2022)
    Table 32. Global Vaccines Administered Orally Revenue Share by Type (2023-2028)
    Table 33. Vaccines Administered Orally Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Vaccines Administered Orally Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 36. Global Vaccines Administered Orally Sales by Application (2023-2028) & (K Units)
    Table 37. Global Vaccines Administered Orally Sales Share by Application (2017-2022)
    Table 38. Global Vaccines Administered Orally Sales Share by Application (2023-2028)
    Table 39. Global Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Vaccines Administered Orally Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Vaccines Administered Orally Revenue Share by Application (2017-2022)
    Table 42. Global Vaccines Administered Orally Revenue Share by Application (2023-2028)
    Table 43. Vaccines Administered Orally Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Vaccines Administered Orally Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 46. North America Vaccines Administered Orally Sales by Type (2023-2028) & (K Units)
    Table 47. North America Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Vaccines Administered Orally Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 50. North America Vaccines Administered Orally Sales by Application (2023-2028) & (K Units)
    Table 51. North America Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Vaccines Administered Orally Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
    Table 54. North America Vaccines Administered Orally Sales by Country (2023-2028) & (K Units)
    Table 55. North America Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Vaccines Administered Orally Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Vaccines Administered Orally Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Vaccines Administered Orally Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Vaccines Administered Orally Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Vaccines Administered Orally Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Vaccines Administered Orally Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Vaccines Administered Orally Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Vaccines Administered Orally Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Vaccines Administered Orally Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Vaccines Administered Orally Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Vaccines Administered Orally Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Vaccines Administered Orally Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Vaccines Administered Orally Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Vaccines Administered Orally Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Vaccines Administered Orally Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Vaccines Administered Orally Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Vaccines Administered Orally Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Vaccines Administered Orally Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Vaccines Administered Orally Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Vaccines Administered Orally Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Vaccines Administered Orally Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Vaccines Administered Orally Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Vaccines Administered Orally Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Vaccines Administered Orally Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Vaccines Administered Orally Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Vaccines Administered Orally Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Major Businesses
    Table 107. Merck Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merck Recent Developments
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Major Businesses
    Table 112. GSK Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GSK Recent Developments
    Table 115. Sanofi Corporation Information
    Table 116. Sanofi Description and Major Businesses
    Table 117. Sanofi Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Sanofi Recent Developments
    Table 120. Lanzhou Institute Corporation Information
    Table 121. Lanzhou Institute Description and Major Businesses
    Table 122. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Lanzhou Institute Recent Developments
    Table 125. Serum Institute Corporation Information
    Table 126. Serum Institute Description and Major Businesses
    Table 127. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Serum Institute Recent Developments
    Table 130. Valneva Corporation Information
    Table 131. Valneva Description and Major Businesses
    Table 132. Valneva Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Valneva Recent Developments
    Table 135. Shanghai United Cell Corporation Information
    Table 136. Shanghai United Cell Description and Major Businesses
    Table 137. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Shanghai United Cell Recent Developments
    Table 140. Bibcol Corporation Information
    Table 141. Bibcol Description and Major Businesses
    Table 142. Bibcol Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Bibcol Recent Developments
    Table 145. PaxVax Corporation Information
    Table 146. PaxVax Description and Major Businesses
    Table 147. PaxVax Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. PaxVax Recent Developments
    Table 150. Vabiotech Corporation Information
    Table 151. Vabiotech Description and Major Businesses
    Table 152. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Vabiotech Recent Developments
    Table 155. Tiantan Biological Corporation Information
    Table 156. Tiantan Biological Description and Major Businesses
    Table 157. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Tiantan Biological Recent Developments
    Table 160. EuBiologics Corporation Information
    Table 161. EuBiologics Description and Major Businesses
    Table 162. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. EuBiologics Recent Developments
    Table 165. Panacea Biotec Ltd Corporation Information
    Table 166. Panacea Biotec Ltd Description and Major Businesses
    Table 167. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Panacea Biotec Ltd Recent Developments
    Table 170. Bio-Med Corporation Information
    Table 171. Bio-Med Description and Major Businesses
    Table 172. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 173. Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Bio-Med Recent Developments
    Table 175. Halfkin Bio-Pharmaceuticals Corporation Information
    Table 176. Halfkin Bio-Pharmaceuticals Description and Major Businesses
    Table 177. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 178. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Halfkin Bio-Pharmaceuticals Recent Developments
    Table 180. Key Raw Materials Lists
    Table 181. Raw Materials Key Suppliers Lists
    Table 182. Vaccines Administered Orally Distributors List
    Table 183. Vaccines Administered Orally Customers List
    Table 184. Vaccines Administered Orally Market Trends
    Table 185. Vaccines Administered Orally Market Drivers
    Table 186. Vaccines Administered Orally Market Challenges
    Table 187. Vaccines Administered Orally Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccines Administered Orally Product Picture
    Figure 3. Global Vaccines Administered Orally Market Share by Type in 2021 & 2028
    Figure 3. Human Product Picture
    Figure 4. Animal Product Picture
    Figure 5. Global Vaccines Administered Orally Market Share by Application in 2021 & 2028
    Figure 6. Public
    Figure 7. Private
    Figure 8. Vaccines Administered Orally Report Years Considered
    Figure 9. Global Vaccines Administered Orally Sales 2017-2028 (K Units)
    Figure 10. Global Vaccines Administered Orally Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Vaccines Administered Orally Revenue 2017-2028 (US$ Million)
    Figure 12. Global Vaccines Administered Orally Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Vaccines Administered Orally Sales Market Share by Region (2017-2022)
    Figure 14. Global Vaccines Administered Orally Sales Market Share by Region (2023-2028)
    Figure 15. North America Vaccines Administered Orally Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Vaccines Administered Orally Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Vaccines Administered Orally Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Vaccines Administered Orally Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Vaccines Administered Orally Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Vaccines Administered Orally Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Vaccines Administered Orally Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Vaccines Administered Orally Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Vaccines Administered Orally Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Vaccines Administered Orally Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Vaccines Administered Orally Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Vaccines Administered Orally in the World: Market Share by Vaccines Administered Orally Revenue in 2021
    Figure 27. Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Vaccines Administered Orally Sales Market Share by Type (2017-2028)
    Figure 29. Global Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
    Figure 30. Global Vaccines Administered Orally Sales Market Share by Application (2017-2028)
    Figure 31. Global Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
    Figure 32. North America Vaccines Administered Orally Sales Market Share by Type (2017-2028)
    Figure 33. North America Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
    Figure 34. North America Vaccines Administered Orally Sales Market Share by Application (2017-2028)
    Figure 35. North America Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
    Figure 36. North America Vaccines Administered Orally Sales Share by Country (2017-2028)
    Figure 37. North America Vaccines Administered Orally Revenue Share by Country (2017-2028)
    Figure 38. U.S. Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Vaccines Administered Orally Sales Market Share by Type (2017-2028)
    Figure 41. Europe Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Vaccines Administered Orally Sales Market Share by Application (2017-2028)
    Figure 43. Europe Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Vaccines Administered Orally Sales Share by Country (2017-2028)
    Figure 45. Europe Vaccines Administered Orally Revenue Share by Country (2017-2028)
    Figure 46. Germany Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 47. France Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Vaccines Administered Orally Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Vaccines Administered Orally Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Vaccines Administered Orally Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Vaccines Administered Orally Revenue Share by Region (2017-2028)
    Figure 57. China Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 60. India Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Vaccines Administered Orally Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Vaccines Administered Orally Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Vaccines Administered Orally Sales Share by Country (2017-2028)
    Figure 72. Latin America Vaccines Administered Orally Revenue Share by Country (2017-2028)
    Figure 73. Mexico Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Vaccines Administered Orally Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Vaccines Administered Orally Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Vaccines Administered Orally Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Vaccines Administered Orally Revenue Share by Country (2017-2028)
    Figure 82. Turkey Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Vaccines Administered Orally Revenue (2017-2028) & (US$ Million)
    Figure 85. Vaccines Administered Orally Value Chain
    Figure 86. Vaccines Administered Orally Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed